Methyltestosterone

Specifications

58-18-4CAS Number

200-366-3EC Number

(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-oneIUPAC Name

C20H30O2Chemical Formula

302.5 g/molMolecular Weight

methyltestosterone; 17-Methyltestosterone; 58-18-4; Metandren; Testred; Android; 17alpha-Methyltestosterone; Androsten; Dumogran; Malestrone; Masenone; Mastestona; Steronyl; Synandrets; Synandrotabs; Hormale; Malogen; Metrone; Testora; Oreton Methyl; Glosso-sterandryl; Neo-Hombreol-M; Oreton-M; Android 5; Methitest; Android 10; Android 25; Orchisterone-M; Metiltestosterona; NSC-9701; Estratest; 17beta-Hydroxy-17-methylandrost-4-en-3-one; Methyltestosteronum; Anertan (tablets); Androsan (tablets); Metiltestosterone; RU 24400; DTXSID1033664; Methyltestosterone ciii; 17alpha-Methyl-3-oxo-4-androsten-17beta-ol; 4-Androstene-17alpha-methyl-17beta-ol-3-one; 17-beta-Hydroxy-17-methylandrost-4-en-3-one; V9EFU16ZIF; L 589.372; NSC-139965; 17alpha-Methyl-delta-androsten-17beta-ol-3-one; CDB-110; Androst-4-en-3-one, 17-hydroxy-17-methyl-, (17beta)-; Androst-4-en-3-one, 17beta-hydroxy-17-methyl-; RU-24400; (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one; DTXCID9013664; CHEBI:27436; NSC9701; U-2842; 17beta-Hydroxy-17alpha-methylandrost-4-en-3-one; L-589372; L-589.372; 17 alpha Methyltestosterone; 17alpha-methyl-Delta4-androsten-17beta-ol-3-one; (17beta)-17-hydroxy-17-methylandrost-4-en-3-one; 17alpha-methyl-Delta(4)-androsten-17beta-ol-3-one; 17(alpha)-methyl-Delta(4)-androsten-17(beta)-ol-3-one; 17beta-Methyltestosterone; 17 beta-Methyltestosterone; 17 Epimethyltestosterone; 17beta Methyltestosterone; 17alpha Methyltestosterone; 17 beta Methyltestosterone; 17alpha Methyl Testosterone; 17alpha-Methyl-Testosterone; Testomet; Testovis; Eldec; Plex hormone; Potensan fte; Neohombreol M; Testotonic B; 17beta-Hydroxy-17-methyl-4-androsten-3-one; Ero Test; 17 beta-Hydroxy-17-methyl-4-androsten-3-one; (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta(a)phenanthren-3-one; RefChem:55623; 17beta Hydroxy 17 methyl 4 androsten 3 one; 17 beta Hydroxy 17 methyl 4 androsten 3 one; G03BA02; G03EK01; 17 Alpha-methyl-delta4-androsten-17beta-ol-4-one; (1S,2R,10R,11S,14S,15S)-14-hydroxy-2,14,15-trimethyltetracyclo(8.7.0.02,7.011,15)heptadec-6-en-5-one; 200-366-3; Androsan; Mesterone; Virilon; Andrometh; Homandren; Metestone; Nabolin; Oraviron; Syndren; M.T.Mucorettes; Nu-man; Testovis Depot; Homandren, tablets; 17-Methyltestosteron; CDB 110; Anertan, tablets; 17-Hydroxy-17-methyl-3-keto-androstene-4; 17-alpha-Methyltestosterone; 17.alpha.-Methyltestosterone; 17|A-Methyltestosterone; U 2842; Oreton M; Androsan, tablets; component of Estan; Neo-Hombreol [M]; Neo-Homobreol (M); Neo-Homobreol [M]; component of Gynetone; NCGC00091009-03; Androst-4-en-3-one, 17-hydroxy-17-methyl-, (17.beta.)-; component of Tylosterone; 17a-methyl testosterone; Glosso sterandryl; Testosterone, 17-methyl-; Homandren (VAN); Testovis (tablet); 17.alpha.-Methyl-3-oxo-4-androsten-17.beta.-ol; Androsan (VAN); Testoviron (VAN); Anertan (VAN); 4-Androstene-17.alpha.-methyl-17.beta.-ol-3-one; Androst-4-en-3-one, 17.beta.-hydroxy-17-methyl-; Testoviron (tablet); Oretron; Estan (Salt/Mix); Metiltestosterone [DCIT]; CAS-58-18-4; Estratest (Salt/Mix); SMR000058528; Android (TN); CCRIS 3723; Methyltestosteronum [INN-Latin]; Metiltestosterona [INN-Spanish]; HSDB 3365; 17?-Methyl Testosterone (1.0 mg/mL in Methanol); WLN: L E5 B666 OV MUTJ A E FQ F -B&AEF; EINECS 200-366-3; UNII-V9EFU16ZIF; NSC 139965; BRN 2057425; component of Gynetone (Salt/Mix); Premarin with methyltestosterone; 4-Androstene-17-alpha-methyl-17-beta-ol-3-one; NCGC00091009-04; NCGC00091009-05; (1S,3aS,3bR,9aR,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one; Testred (TN); (17-beta)-17-Hydroxy-17-methylandrost-4-en-3-one; Premarin with Methyltestosterone (Salt/Mix); 17(alpha)-Methyl-delta4-androsten-17(beta)-ol-3-one; 17-Hydroxy-17-methylandrost-4-en-3-one #; Androst-4-en-3-one, 17-hydroxy-17-methyl-, (17b)-; Methyltestosterone CRS; 17a-methyltestosterone; Methyltestosterone [USP:INN:BAN:JAN]; 17-.beta.-Hydroxy-17-methylandrost-4-en-3-one; Androst-4-en-3-on-17.beta.-ol, 17.alpha.-methyl; METHYL TESTOSTERONE; Methyltestosterone solution; Androst-4-ene-17.alpha.-methyl-17.beta.-ol-3-one; 17.beta.-Hydroxy-17.alpha.-methylandrost-4-en-3-one; 17.alpha.-methyl-.DELTA.4-androsten-17.beta.-ol-3-one; CHEMBL1395; SCHEMBL18657; 4-08-00-01010 (Beilstein Handbook Reference); Androst-4-en-3-one, 17-beta-hydroxy-17-methyl-; MLS000759474; MLS001424040; MLS002174282; GTPL6945; METHYLTESTOSTERONE [INN]; METHYLTESTOSTERONE [JAN]; METHYLTESTOSTERONE [HSDB]; .ALPHA.-METHYLTESTOSTERONE; METHYLTESTOSTERONE [VANDF]; 17-MT; HMS2051A14; HMS2272A06; METHYLTESTOSTERONE [MART.]; METHYLTESTOSTERONE [USP-RS]; METHYLTESTOSTERONE [WHO-DD]; METHYLTESTOSTERONE [WHO-IP]; (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one; 17-METHYLTESTOSTERONE [MI]; HY-A0121; Tox21_113161; Tox21_113162; Tox21_400058; BDBM50410531; LMST02020029; Methyltestosterone (JP17/USP/INN); MSK2221-100A; NSC139965; AKOS015917317; MSK2221-1000A; Tox21_113162_1; CCG-100871; CS-5099; DB06710; GS-6594; NC00121; METHYLTESTOSTERONE [ORANGE BOOK]; METHYLTESTOSTERONE [EP MONOGRAPH]; NCGC00091009-01; NCGC00091009-06; NCGC00091009-07; Oxandrolone impurity, methyltestosterone-; (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one; FM112033; METHYLTESTOSTERONE [USP MONOGRAPH]; METHYLTESTOSTERONUM [WHO-IP LATIN]; SMR001261452; M0435; Methyltestosterone for system suitability CRS; NS00010270; 17alpha-Methyltestosterone, >=97.0% (HPLC); 17Alpha-Methyltestosterone, 1mg/ml in Methanol; C07198; D00408; Methyltestosterone (17alpha-Methyltestosterone); AB00443683-06; AB00443683-09; 17alpha-Methyltestosterone, solid (photosensitive); Q421768; BRD-K84036904-001-08-8; Methyltestosterone Solution in Acetonitrile, 100ug/mL; Methyltestosterone Solution in Acetonitrile, 1000ug/mL; 17-alpha-Methyltestosterone 100 microg/mL in Acetonitrile; 17alpha-Methyltestosterone, VETRANAL(TM), analytical standard; OXANDROLONE IMPURITY, METHYLTESTOSTERONE- [USP IMPURITY]; Methyltestosterone, European Pharmacopoeia (EP) Reference Standard; Methyltestosterone (17alpha-Methyltestosterone) 1.0 mg/ml in Acetonitrile; Methyltestosterone, United States Pharmacopeia (USP) Reference Standard; Methyltestosterone for system suitability, European Pharmacopoeia (EP) Reference Standard; (1S,2R,10R,11S,14S,15S)-14-hydroxy-2,14,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one; (8R,10R,13S,17S)-17-Hydroxy-10,13,17-trimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-oneSynonyms